CoChat

A surge in anti-dsDNA titer predicts a severe lupus flare within six months

Pan, N, Amigues, I, Lyman, S, Duculan, R, Aziz, F, Crow, MK, Kirou, KA · 2014 · Lupus

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Objective: Rising anti-double-stranded (ds) DNA titers have been shown by some, but not all, studies to be predictive of disease flares in systemic lupus erythematosus (SLE). We hypothesized that a rapid and substantial rise in anti-dsDNA titer (anti-dsDNA surge) would be a good predictor of a clinically important SLE flare. Methods: A matched case-control study was conducted in an academic rheumatology practice setting. Our primary endpoint was the occurrence of a severe SELENA-SLEDAI (SS) flare within six months of an anti-dsDNA surge, and secondary endpoints were mild/moderate SS flares, as well as BILAG A and B renal flares. Cases were identified as those patients whose disease course included a surge of anti-dsDNA, defined as an increase of anti-dsDNA titer by the Crithidia luciliae immunofluorescence (CLIF) assay from 0 to 3+/4+, or from 1+ to 4+, within a period of less than 12 months. The date of the anti-dsDNA surge was defined as Day 0. Two control SLE patients were identified for each case and were matched for age, sex, race, and visit date closest to case Day 0, but without an anti-dsDNA surge. Logistic regression models were used to detect associations between anti-dsDNA surges and severe SS flares. Result: A higher proportion of cases, compared to controls, experienced a severe SS flare within six months of Day 0 (OR 6.3 (95% confidence intervals 2.0–19.9), p = 0.02). Associations with all flares and hospitalizations for flares were also observed. However, an anti-dsDNA surge was not predictive of a renal flare. Conclusion: An anti-dsDNA surge predicts the subsequent development of a severe SS flare within six months. Physicians should closely monitor such patients and treat promptly at the first sign of clinical activity.

Overview

Integrity signals

Registry

Crossref · 10.1177/0961203313515763

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 61

Metadata

Authors
Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K.
Affiliations
  • Hospital for Special Surgery (US)
  • St. Luke's-Roosevelt Hospital Center (US)
  • University of Florida Health (US)
  • Hospital for Special Surgery, Division of Rheumatology, NY, USA
Venue
Lupus
Published
2013-12-06
Volume
23
Issue
3
Pages
293-298
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W1968816450
Cited by
59
References
13
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 2
FWCI
3.01
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
systemic lupus erythematosus, anti-dsDNA antibodies, disease flare prediction, SELENA-SLEDAI, renal flares, antibody titer monitoring
MeSH terms
Academic Medical Centers, Adult, Antibodies, Antinuclear, DNA, Female, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Middle Aged, Predictive Value of Tests, Registries, Retrospective Studies, Severity of Illness Index, Time Factors, Biomarkers, Up-Regulation, Chi-Square Distribution, Logistic Models, Odds Ratio, Disease Progression, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A surge in anti-dsDNA titer predicts a severe lupus flare within six months. https://app.cochat.ai/papers/10.1177/0961203313515763
The paper
Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K. (2014). A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus. https://doi.org/10.1177/0961203313515763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.